Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Tobacco smoke exposure and the risk of childhood acute lymphoblastic leukemia and acute myeloid leukemia

View through CrossRef
Abstract Objective: Tobacco smoke contains carcinogens known to damage somatic and germ cells. In this study, we investigated the effect of tobacco smoking on the risk of childhood acute lymphoblastic leukemia (ALL) and myeloid leukemia (AML). Methods: Information about tobacco smoking exposures of the mother before, during, and after pregnancy was collected via PubMed, Embase, and Web of Science databases through November 5, 2018. We performed to evaluate the association between smoking exposure and the risk of childhood ALL and AML. Study selection, data abstraction, and quality assessment were performed by 2 independent reviewers. Random effects models were used to obtain summary odds ratios (ORs) and 95% confidence intervals (CIs). Results: Nineteen case–control studies of childhood leukemia (age < 15 years) conducted in 9 countries from 1974 to 2018. Maternal smoking exposures did not a significant association with childhood ALL (OR = 1.004, 95% CI 0.953–1.058, P = .881) and AML (OR = 0.92, 95% CI 0.815–1.038, P = .177) during exposure time windows. However, there was an association with paternal smoking and ALL (OR = 1.15, 95% CI 1.038–1.275, P = .007). Paternal smoking in AML showed there was no association with smoking exposures and childhood AML (OR = 1.133, 95% CI 0.943–1.362, P = .181). Next, maternal daily cigarettes consumption showed no associations with ALL (OR = 1.08, 95% CI 1.000–1.168, P = .051) during pregnancy. No association with maternal daily smoking and AML (OR = 0.909, 95% CI 0.682–1.211, P = .514). Paternal daily cigarettes consumption was associated with increased risks of childhood ALL (OR = 1.200, 95% CI 1.112–1.302, P = .000). The higher consumption of paternal smoking (more than 10 per day) was significantly related to childhood ALL. Paternal daily smoking consumption also was related to AML (OR = 1.242, 95% CI 1.031–1.496, P = .022). Conclusion: Maternal smoking before, during, or after pregnancy was not associated with childhood ALL or AML. However, paternal smoking was related to a significantly elevated risk of childhood ALL during pregnancy, but not for AML. Maternal daily smoking consumption was not associated with ALL or AML during pregnancy. The higher consumption of paternal smoking were, the higher the risk of childhood ALL or AML.
Title: Tobacco smoke exposure and the risk of childhood acute lymphoblastic leukemia and acute myeloid leukemia
Description:
Abstract Objective: Tobacco smoke contains carcinogens known to damage somatic and germ cells.
In this study, we investigated the effect of tobacco smoking on the risk of childhood acute lymphoblastic leukemia (ALL) and myeloid leukemia (AML).
Methods: Information about tobacco smoking exposures of the mother before, during, and after pregnancy was collected via PubMed, Embase, and Web of Science databases through November 5, 2018.
We performed to evaluate the association between smoking exposure and the risk of childhood ALL and AML.
Study selection, data abstraction, and quality assessment were performed by 2 independent reviewers.
Random effects models were used to obtain summary odds ratios (ORs) and 95% confidence intervals (CIs).
Results: Nineteen case–control studies of childhood leukemia (age < 15 years) conducted in 9 countries from 1974 to 2018.
Maternal smoking exposures did not a significant association with childhood ALL (OR = 1.
004, 95% CI 0.
953–1.
058, P = .
881) and AML (OR = 0.
92, 95% CI 0.
815–1.
038, P = .
177) during exposure time windows.
However, there was an association with paternal smoking and ALL (OR = 1.
15, 95% CI 1.
038–1.
275, P = .
007).
Paternal smoking in AML showed there was no association with smoking exposures and childhood AML (OR = 1.
133, 95% CI 0.
943–1.
362, P = .
181).
Next, maternal daily cigarettes consumption showed no associations with ALL (OR = 1.
08, 95% CI 1.
000–1.
168, P = .
051) during pregnancy.
No association with maternal daily smoking and AML (OR = 0.
909, 95% CI 0.
682–1.
211, P = .
514).
Paternal daily cigarettes consumption was associated with increased risks of childhood ALL (OR = 1.
200, 95% CI 1.
112–1.
302, P = .
000).
The higher consumption of paternal smoking (more than 10 per day) was significantly related to childhood ALL.
Paternal daily smoking consumption also was related to AML (OR = 1.
242, 95% CI 1.
031–1.
496, P = .
022).
Conclusion: Maternal smoking before, during, or after pregnancy was not associated with childhood ALL or AML.
However, paternal smoking was related to a significantly elevated risk of childhood ALL during pregnancy, but not for AML.
Maternal daily smoking consumption was not associated with ALL or AML during pregnancy.
The higher consumption of paternal smoking were, the higher the risk of childhood ALL or AML.

Related Results

Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Are Farmers Willing to Substitute Tobacco Cultivation? Evidence From Lichuan City, China
Are Farmers Willing to Substitute Tobacco Cultivation? Evidence From Lichuan City, China
Abstract Introduction Tobacco crop substitution is a critical element in implementing comprehensive tobacco control policies. Un...
Similarity in the microbial community structure of tobacco from geographically similar regions
Similarity in the microbial community structure of tobacco from geographically similar regions
Abstract To investigate the structural and functional similarities of microbial communities in burnt-sweetness alcoholized tobacco as a function of distance from the equato...
ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia
ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia
Differentiation therapies achieve remarkable success in acute promyelocytic leukemia, a subtype of acute myeloid leukemia. However, excluding acute promyelocytic leukemia, clinical...
STAT3 Mutations in Large Granular Lymphocytic Leukemia
STAT3 Mutations in Large Granular Lymphocytic Leukemia
Abstract Abstract 1606 Introduction: Large granular lymphocytic leukemia (LGL leukemia) is a rare lymphoprolifera...

Back to Top